NCT03007576View on ClinicalTrials.gov

Treatment of Knee Osteoarthritis With Autologous Mesenchymal Stromal Cell Product (RegStem)

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

August 31, 2019

Study Completion Date

August 31, 2019

Conditions
Osteoarthritis,Knee
Interventions
BIOLOGICAL

RegStem

RegStem, 1.5 ml, one injection

Trial Locations (1)

Unknown

Far Eastern Memorial Hospital, Taipei

Sponsors
All Listed Sponsors
collaborator

Far Eastern Memorial Hospital

OTHER

lead

EMO Biomedicine Corporation

INDUSTRY